Sleep Apnea, Obstructive Recruiting Phase 3 Trials for Montelukast (DB00471)

IndicationStatusPhase
DBCOND0030275 (Sleep Apnea, Obstructive)Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03545997Montelukast for Patients With Obstructive Sleep Apnea SyndromeTreatment